INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 42h ago
House PTR2h ago
SEC 13F2h ago
Robinhood Chain2h ago

Most active filers · 30d

  1. 01Kurtz George0B / 220S220 trades$52.89M
  2. 02SPSaba Capital Management, L.P.77B / 19S · 11 late96 trades$25.89M
  3. 03SJSheena Jonathan0B / 57S57 trades$3.61M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SLSpeiser Michael L0B / 35S35 trades$14.00M
  8. 08RARothblatt Martine A0B / 33S33 trades$5.50M
  9. 09RJRubinstein Julie0B / 32S32 trades$5.48M
  10. 10CECrimmins David Edward0B / 31S31 trades$723K

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 631 insiders$417K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 109 insiders$765K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 108 insiders$40.91M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  7. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M
  8. BUYUPBDUPBOUND GROUP, INC.Nov 2 – Nov 37 insiders$1.34M

Form 4 transactions

70,589 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
16
MT
McLain William Thomas Jr.EVP, CFO
EMNEASTMAN CHEMICAL CO
Option exercise
M$196K
3,013 sh
Feb 4, 2026Feb 6, 2026
Page 1314 of 1765
← PrevNext →
traded Feb 4, 2026
+2d
SEC Form 4

Evidence

16
MT
McLain William Thomas Jr.EVP, CFO
EMNEASTMAN CHEMICAL CO
Tax withholding
F$207K
2,636 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

15
BK
Balthaser KevinChief Financial Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
346.8K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
CM
Conner Penelope MDirector
ESEESCO TECHNOLOGIES INC
Option exercise
M$322K
1,349 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

15
MR
McPherson Danny REVP - Technology & CSO
VRSNVERISIGN INC/CA
Tax withholding
F$388K
1,601 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

15
HW
Hall Jesse WayneChief Medical Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
98.1K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
AE
Andrews Charles Elliott Jr.Chief Accounting Officer
CGCarlyle Group Inc.
Tax withholding
F$352K
6,354 sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

15
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
96.1K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
MJ
McKim Scott JosephEVP, Chief Financial Officer
BAFNBayFirst Financial Corp.
Tax withholding
F$592
89 sh
Feb 3, 2026Feb 6, 2026
traded Feb 3, 2026
+3dSEC Form 4

Evidence

15
HL
Hess Janice L.Director
ESEESCO TECHNOLOGIES INC
Option exercise
M$322K
1,349 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

15
HW
Hall Jesse WayneChief Medical Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
343.3K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
OL
Oliver Robin LeighDirector, President, COO
BAFNBayFirst Financial Corp.
Tax withholding
F$891
134 sh
Feb 3, 2026Feb 6, 2026
traded Feb 3, 2026
+3dSEC Form 4

Evidence

15
DM
Davis Hugh M.Director, President and COO
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
336.3K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
BK
Balthaser KevinChief Financial Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
99.1K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
KW
Kolbeck Roland WilhelmChief Scientific Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
95.7K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

15
KW
Kolbeck Roland WilhelmChief Scientific Officer
ACRSAclaris Therapeutics, Inc.
Grant or award
A—
334.9K sh
Feb 2, 2026Feb 6, 2026
traded Feb 2, 2026
+4dSEC Form 4

Evidence

13
PL
Pareja LeonardoCEO of eXp Realty
EXPIAGNT, Inc.
Tax withholding
F$20K
2,283 sh
Feb 6, 2026Feb 6, 2026
traded Feb 6, 2026
+0dSEC Form 4

Evidence

13
PR
Putnam Leah RChief Accounting Officer
BBBYBED BATH & BEYOND, INC.
Option exercise
M$1.93
1,929 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
PR
Putnam Leah RChief Accounting Officer
BBBYBED BATH & BEYOND, INC.
Tax withholding
F$10K
1,820 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Tax withholding
F$31K
5,464 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
SS
StoneBridge Acquisition Sponsor II LLC10% Owner
APACStoneBridge Acquisition II Corp
Grant or award
A—
100.0K sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
PK
Pai KathleenEVP, Chief People Officer
NABLN-able, Inc.
Grant or award
A—
50.8K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
CL
Claxton Timothy L.Director
SBFGSB FINANCIAL GROUP, INC.
Grant or award
A$25K
1,150 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
MA
Musial Nickolas A.VP, Controller & CAO
ALLEAllegion plc
Grant or award
A—
557 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
KS
Klaus Andrew SCFO
PLPCPREFORMED LINE PRODUCTS CO
Grant or award
A—
1,785 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
OJ
Olenik John JVP-Research & Engineering
PLPCPREFORMED LINE PRODUCTS CO
Grant or award
A—
1,160 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Option exercise
M$6.17
6,172 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
HJ
Honeycutt JenniferDirector, President and CEO
VLTOVeralto Corp
Grant or award
A—
2,766 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
YR
Young Joseph RSVP, FINANCE, CHIEF ACCT OFFCR
VERAVera Therapeutics, Inc.
Grant or award
A—
10.0K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
HP
Hill Jesse P.Chief Financial Officer
EXPIAGNT, Inc.
Tax withholding
F$5,370
637 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
LC
Lee CindyChief Financial Officer
VIRTVirtu Financial, Inc.
Option exercise
M—
1,172 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
AP
Antony PrabhuDirector, Chief Financial Officer, 10% Owner
APACStoneBridge Acquisition II Corp
Grant or award
A—
100.0K sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
LC
Lee CindyChief Financial Officer
VIRTVirtu Financial, Inc.
Grant or award
A—
5,523 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
OJ
O'Brien Tim JamesEVP, Chief Financial Officer
NABLN-able, Inc.
Grant or award
A—
91.4K sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
MR
McPherson Danny REVP - Technology & CSO
VRSNVERISIGN INC/CA
Grant or award
A—
4,810 sh
Feb 5, 2026Feb 6, 2026
traded Feb 5, 2026
+1dSEC Form 4

Evidence

13
OP
O'Meara Brien P.Vice President & Controller
PHMPULTEGROUP INC/MI/
Grant or award
A—
1,010 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
LA
Lee AdriannePresident & CFO
BBBYBED BATH & BEYOND, INC.
Option exercise
M$0.52
5,238 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
SV
Sriram VandanaChief Financial Officer
QTRXQuanterix Corp
Tax withholding
F—
4,395 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
LC
Lee CindyChief Financial Officer
VIRTVirtu Financial, Inc.
Grant or award
A—
8,284 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence

13
PR
Putnam Leah RChief Accounting Officer
BBBYBED BATH & BEYOND, INC.
Tax withholding
F$2,743
488 sh
Feb 4, 2026Feb 6, 2026
traded Feb 4, 2026
+2dSEC Form 4

Evidence